Gustavo Lorente

1.1k total citations
13 papers, 854 citations indexed

About

Gustavo Lorente is a scholar working on Molecular Biology, Immunology and Allergy and Cancer Research. According to data from OpenAlex, Gustavo Lorente has authored 13 papers receiving a total of 854 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Immunology and Allergy and 5 papers in Cancer Research. Recurrent topics in Gustavo Lorente's work include Cell Adhesion Molecules Research (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Sarcoma Diagnosis and Treatment (3 papers). Gustavo Lorente is often cited by papers focused on Cell Adhesion Molecules Research (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Sarcoma Diagnosis and Treatment (3 papers). Gustavo Lorente collaborates with scholars based in United States, New Zealand and Germany. Gustavo Lorente's co-authors include Erik D. Foehr, Roman Urfer, Karoly Nikolich, Usha Nagavarapu, April Nelson, Charles P. Hart, James Evans, Monica Banica, Lingyun Lan and Jianxin Duan and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.

In The Last Decade

Gustavo Lorente

13 papers receiving 826 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gustavo Lorente United States 9 471 354 212 130 124 13 854
Mirjam Hermisson Germany 14 614 1.3× 232 0.7× 229 1.1× 74 0.6× 137 1.1× 17 1.1k
Caroline Delmas France 22 794 1.7× 433 1.2× 408 1.9× 141 1.1× 110 0.9× 37 1.4k
Gabriel J. Villares United States 18 666 1.4× 271 0.8× 330 1.6× 124 1.0× 96 0.8× 19 1.2k
Shahinoor Begum United States 8 404 0.9× 160 0.5× 409 1.9× 104 0.8× 140 1.1× 13 988
Ross Lake United States 15 741 1.6× 196 0.6× 269 1.3× 83 0.6× 229 1.8× 22 1.1k
Narra S. Devi United States 16 710 1.5× 325 0.9× 266 1.3× 77 0.6× 130 1.0× 20 1.1k
Timothy J. Mead United States 16 506 1.1× 276 0.8× 112 0.5× 112 0.9× 126 1.0× 27 1.0k
Taru Muranen United States 13 555 1.2× 177 0.5× 383 1.8× 81 0.6× 97 0.8× 25 1.1k
Ángel Santiago Mexico 9 697 1.5× 261 0.7× 325 1.5× 103 0.8× 69 0.6× 16 908
Myriam Maoz Israel 17 428 0.9× 298 0.8× 180 0.8× 111 0.9× 77 0.6× 30 902

Countries citing papers authored by Gustavo Lorente

Since Specialization
Citations

This map shows the geographic impact of Gustavo Lorente's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gustavo Lorente with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gustavo Lorente more than expected).

Fields of papers citing papers by Gustavo Lorente

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gustavo Lorente. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gustavo Lorente. The network helps show where Gustavo Lorente may publish in the future.

Co-authorship network of co-authors of Gustavo Lorente

This figure shows the co-authorship network connecting the top 25 collaborators of Gustavo Lorente. A scholar is included among the top collaborators of Gustavo Lorente based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gustavo Lorente. Gustavo Lorente is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Konopleva, Marina, Damian Handisides, Gustavo Lorente, et al.. (2012). Phase I study of TH-302, a hypoxia-activated cytotoxic prodrug, in subjects with advanced leukemias.. Journal of Clinical Oncology. 30(15_suppl). 6585–6585. 3 indexed citations
2.
Meng, Fanying, James Evans, Monica Banica, et al.. (2011). Molecular and Cellular Pharmacology of the Hypoxia-Activated Prodrug TH-302. Molecular Cancer Therapeutics. 11(3). 740–751. 160 indexed citations
3.
Ganjoo, Kristen N., Lee D. Cranmer, James E. Butrynski, et al.. (2011). A Phase I Study of the Safety and Pharmacokinetics of the Hypoxia-Activated Prodrug TH-302 in Combination with Doxorubicin in Patients with Advanced Soft Tissue Sarcoma. Oncology. 80(1-2). 50–56. 65 indexed citations
4.
Cranmer, Lee D., Kristen N. Ganjoo, Douglas R. Adkins, et al.. (2011). A phase II dose expansion of TH-302 in combination with doxorubicin in soft-tissue sarcoma.. Journal of Clinical Oncology. 29(15_suppl). 10024–10024. 1 indexed citations
5.
Cranmer, Lee D., Sant P. Chawla, Daniel A. Rushing, et al.. (2010). Phase I/II study of TH-302 combined with doxorubicin in soft tissue sarcoma.. Journal of Clinical Oncology. 28(15_suppl). 10036–10036. 4 indexed citations
6.
Hart, Charles P., Fanying Meng, Monica Banica, et al.. (2008). In vitro activity profile of the novel hypoxia-activated cytotoxic prodrug TH-302. Cancer Research. 68. 1441–1441. 1 indexed citations
7.
Duan, Jianxin, Jacob A. Kaizerman, Timothy F. Stanton, et al.. (2008). Potent and Highly Selective Hypoxia-Activated Achiral Phosphoramidate Mustards as Anticancer Drugs. Journal of Medicinal Chemistry. 51(8). 2412–2420. 188 indexed citations
8.
Foehr, Erik D., et al.. (2006). Targeting of the Receptor Protein Tyrosine Phosphatase β with a Monoclonal Antibody Delays Tumor Growth in a Glioblastoma Model. Cancer Research. 66(4). 2271–2278. 56 indexed citations
9.
Shashidhar, Sumana, Gustavo Lorente, Usha Nagavarapu, et al.. (2005). GPR56 is a GPCR that is overexpressed in gliomas and functions in tumor cell adhesion. Oncogene. 24(10). 1673–1682. 139 indexed citations
10.
Ram, Rosalyn, Gustavo Lorente, Karoly Nikolich, et al.. (2005). Discoidin Domain Receptor-1a (DDR1a) Promotes Glioma Cell Invasion and Adhesion in Association with Matrix Metalloproteinase-2. Journal of Neuro-Oncology. 76(3). 239–248. 95 indexed citations
11.
Lorente, Gustavo, et al.. (2005). Functional comparison of long and short splice forms of RPTPβ:Implications for glioblastoma treatment. Neuro-Oncology. 7(2). 154–163. 14 indexed citations
12.
Foehr, Erik D., Gustavo Lorente, V.A.M. Vincent, Karoly Nikolich, & Roman Urfer. (2005). FAS Associated Phosphatase (FAP-1) Blocks Apoptosis of Astrocytomas through Dephosphorylation of FAS. Journal of Neuro-Oncology. 74(3). 241–248. 28 indexed citations
13.
Müller, Sabine, Philip Kunkel, Katrin Lamszus, et al.. (2003). A role for receptor tyrosine phosphataseζ in glioma cell migration. Oncogene. 22(43). 6661–6668. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mirjam Hermisson Breakdown of academic impact, for papers by Caroline Delmas Breakdown of academic impact, for papers by Gabriel J. Villares Breakdown of academic impact, for papers by Shahinoor Begum Breakdown of academic impact, for papers by Ross Lake Breakdown of academic impact, for papers by Narra S. Devi Breakdown of academic impact, for papers by Timothy J. Mead Breakdown of academic impact, for papers by Taru Muranen Breakdown of academic impact, for papers by Ángel Santiago Breakdown of academic impact, for papers by Myriam Maoz
Rankless by CCL
2026